新浪财经ESG：Theravance Biopharma Inc. - Ordinary Sh...
Theravance Biopharma(US:TBPH) Xin Lang Cai Jing·2025-10-30 23:09Core Insights - Theravance Biopharma Inc. has received an upgrade in its MSCI ESG rating from BBB to A as of October 30, 2025 [1] Company Summary - The upgrade reflects an improvement in Theravance Biopharma's environmental, social, and governance practices [1]